Diabetes mellitus in elderly

Indian Journal of Endocrinology and Metabolism

Volumn 19, Issue 6, 2015, Pages 744-752

  Chentli, Farida ^a   Azzoug, Said ^a   Mahgoun, Souad ^a  

^a Bab El Oued Hospital   (Algeria)

Author keywords

Cognitive impairment; complications; diabetes mellitus; elderly; insulin resistance; micro nutriments; treatment individualization

Indexed keywords

EID: 84981356520     PISSN: 22308210     EISSN: 22309500     Source Type: Journal    
DOI: 10.4103/2230-8210.167553     Document Type: Review

References (70)

1. Alqahtani N, Khan WA, Alhumaidi MH, Ahmed YA. Use of glycated hemoglobin in the diagnosis of diabetes mellitus and pre-diabetes and role of fasting plasma glucose, oral glucose tolerance test. Int J Prev Med 2013;4:1025-9.
2. Hu Y, Liu W, Chen Y, Zhang M, Wang L, Zhou H, et al. Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2010;47:231-6.
3. d'Emden MC, Shaw JE, Jones GR, Cheung NW. Guidance concerning the use of glycated haemoglobin (HbA1c) for the diagnosis of diabetes mellitus. Med J Aust 2015;203:89-90.
4. ADA. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008;31 Suppl 1:S62-7.
5. Fowler MJ. Microvascular and macrovascular complications of diabetes. Clin Diabetes 2008;26:77-82.
6. Heydari I, Radi V, Razmjou S, Amiri A. Chronic complications of diabetes mellitus in newly diagnosed patients. Int J Diabetes Mellitus 2010;2:61-3.
7. Borissova AM, Shinkov A, Kovatcheva R, Vlahov J, Dakovska L, Todorov T. Changes in the prevalence of diabetes mellitus in Bulgaria (2006-2012). Clin Med Insights Endocrinol Diabetes 2015;8:41-5.
8. Nguyen TH, Nguyen TN, Fischer T, Ha W, Tran TV. Type 2 diabetes among Asian Americans: Prevalence and prevention. World J Diabetes 2015;6:543-7.
9. Lam DW, LeRoith D. The worldwide diabetes epidemic. Curr Opin Endocrinol Diabetes Obes 2012;19:93-6.
10. Kalra S, Kumar A, Jarhyan P, Unnikrishnan AG. Endemic or epidemic? Measuring the endemicity index of diabetes. Indian J Endocrinol Metab 2015;19:5-7.
11. Sloan FA, Bethel MA, Ruiz D Jr, Shea AM, Feinglos MN. The growing burden of diabetes mellitus in the US elderly population. Arch Intern Med 2008;168:192-9.
12. Caspersen CJ, Thomas GD, Boseman LA, Beckles GL, Albright AL. Aging, diabetes, and the public health system in the United States. Am J Public Health 2012;102:1482-97.
13. Hornick T, Aron DC. Managing diabetes in the elderly: Go easy, individualize. Cleve Clin J Med 2008;75:70-8.
14. WHO definition of an older or elderly person. Available from: http://www.who.int/healthinfo/survey/ageingdefnolder/en/. [Last accessed on 2015 Sep 04].
15. Orimo H, Ito H, Suzuki T, Araki A, Hosoi T, Sawabe M. Reviewing the definition of 'elderly'. Geriatr Gerontol Int 2006;6:149-58.
16. Sinclair A, Dunning T, Colagiuris S. Managing older people with type 2 diabetes: Global guideline IDF 2013. Available from: http://www.idf.org/guidelines/managing-older-people-type-2-diabetes. [Last accessed on 2015 Sep 29].
17. Available from: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf. [Last access on 2015 Sep 05].
18. Sinclair A, Morley JE, Rodriguez-Mañas L, Paolisso G, Bayer T, Zeyfang A, et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. J Am Med Dir Assoc 2012;13:497-502.
19. International Diabetes Federation. IDF Diabetes Atlas. 5th ed. Brussels, Belgium: International Diabetes Federation; 2011.
20. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. Diabetes Care 2012;35:2650-64.
21. Crandel J. Pharmacotherapy in older adults. ADA; 2014. Available from: http://www.professional.diabetes.org/admin/UserFiles/CE/PG/Crandall%20-%20ADA%20post%20grad%202014.pdf. [Last access on 2015 Sep 04].
22. Tyrovolas S, Koyanagi A, Garin N, Olaya B, Ayuso-Mateos JL, Miret M, et al. Diabetes mellitus and its association with central obesity and disability among older adults: A global perspective. Exp Gerontol 2015;64:70-7.
23. Wannamethee SG, Welsh P, Papacosta O, Lennon L, Whincup PH, Sattar N. Copeptin, insulin resistance and risk of incident diabetes in older men. J Clin Endocrinol Metab 2015;100:3332-9.
24. Enhörning S, Struck J, Wirfält E, Hedblad B, Morgenthaler NG, Melander O. Plasma copeptin, a unifying factor behind the metabolic syndrome. J Clin Endocrinol Metab 2011;96:E1065-72.
25. Sung CC, Liao MT, Lu KC, Wu CC. Role of vitamin D in insulin resistance. J Biomed Biotechnol 2012;2012:634195.
26. Li YX, Zhou L. Vitamin D deficiency, obesity and diabetes. Cell Mol Biol (Noisy-le-grand) 2015;61:35-8.
27. Cândido FG, Bressan J. Vitamin D: Link between osteoporosis, obesity, and diabetes? Int J Mol Sci 2014;15:6569-91.
28. Keeney JT, Butterfield DA. Vitamin D deficiency and Alzheimer disease: Common links. Neurobiol Dis 2015:pii: S0969-996130004-8.
29. Keeney JT, Förster S, Sultana R, Brewer LD, Latimer CS, Cai J, et al. Dietary vitamin D deficiency in rats from middle to old age leads to elevated tyrosine nitration and proteomics changes in levels of key proteins in brain: Implications for low vitamin D-dependent age-related cognitive decline. Free Radic Biol Med 2013;65:324-34.
30. Rodríguez-Morán M, Simental Mendía LE, Zambrano Galván G, Guerrero-Romero F. The role of magnesium in type 2 diabetes: A brief based-clinical review. Magnes Res 2011;24:156-62.
31. Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: A review. Biol Trace Elem Res 2010;134:119-29.
32. Dasgupta A, Sarma D, Saikia UK. Hypomagnesemia in type 2 diabetes mellitus. Indian J Endocrinol Metab 2012;16:1000-3.
33. Chau D, Edelman SV. Clinical management of diabetes in the elderly. Clin Diabetes 2001;19:172-5.
34. Hossein-Nezhad A, Holick MF. Vitamin D for health: A global perspective. Mayo Clin Proc 2013;88:720-55.
35. Owens D, Kalra S, Sahay R. Geriatric endocrinology. Indian J Endocrinol Metab 2011;15:71-2.
36. Walston JD. Sarcopenia in older adults. Curr Opin Rheumatol 2012;24:623-7.
37. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-23.
38. Keevil VL, Romero-Ortuno R. Ageing well: A review of sarcopenia and frailty. Proc Nutr Soc 2015;25:1-11.
39. Oliveira A, Vaz C. The role of sarcopenia in the risk of osteoporotic hip fracture. Clin Rheumatol 2015;34:1673-80.
40. Curtis E, Litwic A, Cooper C, Dennison E. Determinants of muscle and bone aging. J Cell Physiol 2015;230:2618-25.
41. Jain A, Paranjape S. Prevalence of type 2 diabetes mellitus in elderly in a primary care facility: An ideal facility. Indian J Endocrinol Metab 2013;17 Suppl 1:S318-22.
42. Chen ST, Siddarth P, Ercoli LM, Merrill DA, Torres-Gil F, Small GW. Modifiable risk factors for Alzheimer disease and subjective memory impairment across age groups. PLoS One 2014;9:e98630.
43. Altabas V. Diabetes, endothelial dysfunction, and vascular repair: What should a diabetologist keep his eye on? Int J Endocrinol 2015;2015:848272.
44. Bani-Issa W, Almomani F, Eldeirawi K. Urinary incontinence among adult women with diabetes in Jordan: Epidemiology, correlates and perceived impact on emotional and social well-being. J Clin Nurs 2014;23:2451-60.
45. Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev 2014;1:CD002115.
46. Taheri Tanjani P, Moradinazar M, Esmail Mottlagh M, Najafi F. The prevalence of diabetes mellitus (DM) type II among Iranian elderly population and its association with other age-related diseases, 2012. Arch Gerontol Geriatr 2015;60:373-9.
47. Baruah MP, Kalra S, Unnikrishnan AG, Raza SA, Somasundaram N, John M, et al. Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines. Indian J Endocrinol Metab 2011;15:75-90.
48. Teshima N, Shimo M, Miyazawa K, Konegawa S, Matsumoto A, Onishi Y, et al. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: The mihama diabetes prevention study. J Nutr Sci Vitaminol (Tokyo) 2015;61:14-9.
49. Wedick NM, Barrett-Connor E, Knoke JD, Wingard DL. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: The Rancho Bernardo study. J Am Geriatr Soc 2002;50:1810-5.
50. Weisenberger J. Elder diabetes patients: Know the signs and symptoms of type 2 diabetes in this population to improve care. Today's Dietitian 2013;15:20. Available from: http://www.todaysdietitian.com/newarchives/030413p20.shtml. [Last accessed on 2015 Sep 30].
51. Almaleki N, Ashraf M, Hussein MM, Mohiuddin SA. Metformin-associated lactic acidosis in a peritoneal dialysis patient. Saudi J Kidney Dis Transpl 2015;26:325-8.
52. Kim MJ, Han JY, Shin JY, Kim SI, Lee JM, Hong S, et al. Metformin-associated lactic acidosis: Predisposing factors and outcome. Endocrinol Metab (Seoul) 2015;30:78-83.
53. Haeusler S, Parry-Strong A, Krebs JD. The prevalence of low vitamin B12 status in people with type 2 diabetes receiving metformin therapy in New Zealand-a clinical audit. N Z Med J 2014;127:8-16.
54. Bell DS. Metformin-induced vitamin B12 deficiency presenting as a peripheral neuropathy. South Med J 2010;103:265-7.
55. Ting RZ, Szeto CC, Chan MH, Ma KK, Chow KM. Risk factors of vitamin B (12) deficiency in patients receiving metformin. Arch Intern Med 2006;166:1975-9.
56. Halimi S, Raccah D, Schweizer A, Dejager S. Role of vildagliptin in managing type 2 diabetes mellitus in the elderly. Curr Med Res Opin 2010;26:1647-56.
57. Shankar RR, Xu L, Golm GT, O'Neill EA, Goldstein BJ, Kaufman KD, et al. A comparison of glycaemic effects of sitagliptin and sulfonylureas in elderly patients with type 2 diabetes mellitus. Int J Clin Pract 2015;69:626-31.
58. Bode BW, Brett J, Falahati A, Pratley RE. Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes≥65 and<65 years of age: A pooled analysis from phase III studies. Am J Geriatr Pharmacother 2011;9:423-33.
59. Duarte AI, Candeias E, Correia SC, Santos RX, Carvalho C, Cardoso S, et al. Crosstalk between diabetes and brain: Glucagon-like peptide-1 mimetics as a promising therapy against neurodegeneration. Biochim Biophys Acta 2013;1832:527-41.
60. Yabe D, Nishikino R, Kaneko M, Iwasaki M, Seino Y. Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: Considerations for their appropriate use to avoid serious adverse events. Expert Opin Drug Saf 2015;14:795-800.
61. Mikhail N. Place of sodium-glucose co-transporter type 2 inhibitors for treatment of type 2 diabetes. World J Diabetes 2014;5:854-9.
62. Herrmann K, Shan K, Brunell SC, Chen S. Effects of pramlintide in patients with type 2 diabetes mellitus: An analysis using daily insulin dose tertiles. Endocr Pract 2014;20:1070-5.
63. Benroubi M. Fear, guilt feelings and misconceptions: Barriers to effective insulin treatment in type 2 diabetes. Diabetes Res Clin Pract 2011;93 Suppl 1:S97-9.
64. Haugstvedt A, Wentzel-Larsen T, Graue M, Søvik O, Rokne B. Fear of hypoglycaemia in mothers and fathers of children with Type 1 diabetes is associated with poor glycaemic control and parental emotional distress: A population-based study. Diabet Med 2010;27:72-8.
65. Davidson JA. Case study: Lessons learned in the care of a 63-year-old woman with type 2 diabetes. Clin Cornerstone 2005;7 Suppl 3:S18-24.
66. Nam S, Chesla C, Stotts NA, Kroon L, Janson SL. Barriers to diabetes management: Patient and provider factors. Diabetes Res Clin Pract 2011;93:1-9.
67. Moser EG, Morris AA, Garg SK. Emerging diabetes therapies and technologies. Diabetes Res Clin Pract 2012;97:16-26.
68. Sousa F, Castro P, Fonte P, Sarmento B. How to overcome the limitations of current insulin administration with new non-invasive delivery systems. Ther Deliv 2015;6:83-94.
69. Arbouche Z. Diabetes in Eldely: A Maghrebin Study. 9th Congress of Endocrinology and Diabetology. Algiers 23-25 November, 2012.
70. Boquete L, Rodriguez-Ascariz JM, Artacho I, Cantos-Frontela J, Peixoto N. Dynamically programmable electronic pill dispenser system. J Med Syst 2010;34:357-66.